ULI New York Presents: Unlocking Life Science Real Estate’s Potential In NYC
As part of its ten year, $500 million commitment to growing New York City’s life science cluster, the New York City Economic Development Corporation issued an RFEI for $100 million in capital to help unlock space for companies to grow, and build a pipeline for diverse life science talent. This money has brought unprecedented attention to this burgeoning industry, but there are a number of other efforts underway throughout the City – both related and unrelated to the City’s most recent initiative – that are worth further examination.
Join ULI New York on May 30 at the New York Genome Center to hear from a panel of life science experts who will discuss the state of life science real estate in New York City. The panel will discuss some of the factors that have stymied growth of this industry to date, including misconceptions regarding use, the high cost of wet laboratory construction, credit issues of small and start-up companies and zoning/use group challenges. The panel will also discuss some reasons for optimism within the real estate industry.
Wednesday, May 30, 2018
8:00 AM – 8:30 AM Registration & Breakfast
8:30 AM – 10:00 AM Panel Discussion
Doug Thiede | Senior VP, Life Sciences & Healthcare | NYCEDC
Robert Albro | Managing Director | King Street Properties
Sam Globus | Vice President, Business Strategy & Operations | Celmatix
Kate Merton | Head of Johnson & Johnson Innovation | JLABS in New York